[Beta 2 agonists and the course of bronchial asthma].
Chazan
R
R
Kliniki Pneumologii Warszawskiej Akademii Medycznej.
Droszcz
W
W
D000280:Administration, Inhalation; D000318:Adrenergic beta-Agonists / Q000008:administration & dosage*; D000420:Albuterol / Q000008:administration & dosage* / Q000031:analogs & derivatives*; D001249:Asthma / Q000188:drug therapy*; D001980:Bronchi / Q000187:drug effects*; D006801:Humans; D009130:Muscle, Smooth / Q000187:drug effects*; D011943:Receptors, Adrenergic, beta / Q000187:drug effects*; D000068299:Salmeterol Xinafoate; D013997:Time Factors
D000318:Adrenergic beta-Agonists; D011943:Receptors, Adrenergic, beta; D000068299:Salmeterol Xinafoate; D000420:Albuterol
Beta 2--agoniści a przebieg astmy oskrzelowej.